MRK Stock Quote Price and Forecast | CNN

MRK

Merck & Co., Inc.

Key terms

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Sector

Industry

Employees

Founded

Website

Key stock statistics

1-day range

52-week range

Market cap

P/E ratio

Next earnings date

Dividend yield

Ex-dividend date

Dividend pay date

Key terms

Smart score

Apr 12 5:06am ET Merck & Company: Balancing Growth Prospects Against Rising Operational Challenges by TipRanks Apr 08 2:43pm ET Moderna Stock (NASDAQ:MRNA): This mRNA Tech Pioneer Has Rebound Potential by TipRanks Apr 08 10:07am ET Merck price target raised to $143 from $140 at Berenberg by TipRanks Apr 06 12:15am ET Merck & Company (MRK) Receives a Buy from Cantor Fitzgerald by TipRanks Apr 04 12:10pm ET Piper Sandler pharmaceuticals analysts hold an analyst/industry conference call by TipRanks Apr 04 6:49am ET Merck initiates Phase 3 clinical trial of MK-1084 by TipRanks Apr 03 8:11am ET Daiichi Sankyo, Merck announe first patient dosed in REJOICE-Ovarian01 trial by TipRanks Apr 02 4:25am ET Cantor Fitzgerald Remains a Buy on Merck & Company (MRK) by TipRanks Mar 29 3:06am ET Buy Rating on Merck & Co. Affirmed by Daina Graybosch Amidst WINREVAIR’s Market Potential and Efficacy by TipRanks Mar 28 9:00am ET Merck price target raised to $142 from $139 at Truist by TipRanks Mar 28 7:05am ET PDS Biotechnology price target lowered to $5 from $16 at Alliance Global Partners by TipRanks Mar 28 6:48am ET Merck: EC approves Keytruda plus chemotherapy to treat NSCLC by TipRanks Mar 28 12:20am ET Analysts Offer Insights on Healthcare Companies: Resmed (RMD) and Merck & Company (MRK) by TipRanks Mar 27 9:56am ET Early notable gainers among liquid option names on March 27th by TipRanks Mar 27 7:19am ET Winrevair label represents ‘most bullish scenario’ for Merck, says BofA by TipRanks Mar 27 6:12am ET Merck price target raised to $135 from $130 at Wells Fargo by TipRanks Mar 26 7:56pm ET Merck & Co. Buy Rating Affirmed on Strong Sotatercept Outlook and Robust Growth Trajectory by TipRanks Mar 26 6:23pm ET Merck confirms FDA approval of WINREVAIR by TipRanks Mar 26 4:58pm ET Merck’s hypertension drug Sotatercept gains FDA approval, Bloomberg says by TipRanks Mar 25 4:14pm ET Summit Therapeutics initiated with a Buy at Stifel by TipRanks Mar 22 7:06am ET Merck & Company (MRK) Receives a Buy from Truist Financial by TipRanks Mar 21 6:46am ET Merck: Phase 3 KEYLYNK-006 trial did not meet dual primary endpoints by TipRanks Mar 19 9:08am ET Merck: V116 vaccine for pneumococcal diseases show adult immune response by TipRanks Mar 18 8:30am ET Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Legend Biotech (LEGN) by TipRanks Mar 15 2:37pm ET Buy/Sell: Wall Street’s top 10 stock calls this week by TipRanks Mar 15 10:45am ET Merck call volume above normal and directionally bullish by TipRanks Mar 15 6:46am ET Merck says Phase 3 KEYNOTE-A18 trial met primary endpoint by TipRanks Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 5:21am ET Merck to conduct trials for HPV vaccine, Gardasil by TipRanks Mar 13 2:11am ET Analysts Are Bullish on Top Healthcare Stocks: Biogen (BIIB), Merck & Company (MRK) by TipRanks Mar 12 12:25pm ET Moderna, Merck start two randomized trial in cancers, says RBC Capital by TipRanks

Mar 28 9:15am ET How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together by Accesswire Mar 26 9:30am ET Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Region by Accesswire

1-year income & revenue

Key terms

analyst rating

buy
hold
sell

1-year stock price forecast

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.

Frank Franklin II/AP

Trump Media stock ends session 15% higher after two very bad days

Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.

Patrick Reddy/The Enquirer/AP/File

Private equity finds its next bet: college admissions

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.

Scott Olson/Getty Images

Trump’s stock tumbles again after Truth Social announces it’s getting into streaming

Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images

Samuel Corum/Bloomberg/Getty Images

Geopolitical strife is roiling Wall Street. Here’s what investors are watching